Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seng-Gee Lim

Showing results (71-80 of 219) with videos related to

Pageof 22
Sort By:
Journal of Medical Virology|March 1, 2018
Pyrosequencing method for sensitive detection of HBV drug resistance mutationsGuan-Huei Lee, Masafumi Inoue, Roxanne Hui-Heng Chong, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 4, 2007
Drug-induced liver injury at an Asian center: a prospective studyChun-Tao Wai, Bee-Him Tan, Cheng-Leng Chan, et al.
World Journal of Gastroenterology|August 27, 2005
Misperceptions among patients with chronic hepatitis B in SingaporeChun-Tao Wai, Belinda Mak, Winnie Chua, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 13, 2024
Stopping Nucleos(t)ide Analogues in Chronic Hepatitis B Using HBsAg Thresholds: A Meta-Analysis and Meta-RegressionSeng Gee Lim, Ada Ee Der Teo, Edwin Shih-Yen Chan, et al.
Antiviral Therapy|December 13, 2012
Patient preferences for hepatitis B therapySeng Gee Lim, Myat Oo Aung, Stephanie W M Chung, et al.
Hepatology International|April 13, 2011
Risk factors for mortality in cirrhotic patients with sepsisLee-Guan Lim, Xiang-Xuan Eunice Tan, Shu-Jeng Woo, et al.
Antiviral Research|March 28, 2006
Synthesis and the biological evaluation of 2-benzenesulfonylalkyl-5-substituted-sulfanyl-[1,3,4]-oxadiazoles as potential anti-hepatitis B virus agentsTheresa May Chin Tan, Yu Chen, Kah Hoe Kong, et al.
Antiviral Research|January 13, 2006
Are in vitro hepatitis B core promoter mutations important for clinical alterations in viral load?Yan Cheng, Bee Leng Seet, Carmen Shair Ling Ong, et al.
Frontiers in Cellular and Infection Microbiology|June 8, 2026
HBx interacts with the host YBX3 protein and up-regulates its expression to mediate efficient Hepatitis B viral replicationMel Veen Boo, Jackie Chu, ZiJie Lim, et al.
Virology Journal|June 21, 2005
Genetic lesions within the 3a gene of SARS-CoVTimothy H P Tan, Timothy Barkham, Burtram C Fielding, et al.
Pageof 22

Showing results (71-80 of 219) with videos related to

Sort By:
Pageof 22
Journal of Medical Virology|March 1, 2018
Pyrosequencing method for sensitive detection of HBV drug resistance mutationsGuan-Huei Lee, Masafumi Inoue, Roxanne Hui-Heng Chong, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 4, 2007
Drug-induced liver injury at an Asian center: a prospective studyChun-Tao Wai, Bee-Him Tan, Cheng-Leng Chan, et al.
World Journal of Gastroenterology|August 27, 2005
Misperceptions among patients with chronic hepatitis B in SingaporeChun-Tao Wai, Belinda Mak, Winnie Chua, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 13, 2024
Stopping Nucleos(t)ide Analogues in Chronic Hepatitis B Using HBsAg Thresholds: A Meta-Analysis and Meta-RegressionSeng Gee Lim, Ada Ee Der Teo, Edwin Shih-Yen Chan, et al.
Antiviral Therapy|December 13, 2012
Patient preferences for hepatitis B therapySeng Gee Lim, Myat Oo Aung, Stephanie W M Chung, et al.
Hepatology International|April 13, 2011
Risk factors for mortality in cirrhotic patients with sepsisLee-Guan Lim, Xiang-Xuan Eunice Tan, Shu-Jeng Woo, et al.
Antiviral Research|March 28, 2006
Synthesis and the biological evaluation of 2-benzenesulfonylalkyl-5-substituted-sulfanyl-[1,3,4]-oxadiazoles as potential anti-hepatitis B virus agentsTheresa May Chin Tan, Yu Chen, Kah Hoe Kong, et al.
Antiviral Research|January 13, 2006
Are in vitro hepatitis B core promoter mutations important for clinical alterations in viral load?Yan Cheng, Bee Leng Seet, Carmen Shair Ling Ong, et al.
Frontiers in Cellular and Infection Microbiology|June 8, 2026
HBx interacts with the host YBX3 protein and up-regulates its expression to mediate efficient Hepatitis B viral replicationMel Veen Boo, Jackie Chu, ZiJie Lim, et al.
Virology Journal|June 21, 2005
Genetic lesions within the 3a gene of SARS-CoVTimothy H P Tan, Timothy Barkham, Burtram C Fielding, et al.
Pageof 22